Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2025-12-26 @ 3:28 AM
Study NCT ID:
NCT03978520
Status:
COMPLETED
Last Update Posted:
2023-07-21
First Post:
2019-06-03
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-25
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-14
Completion Date Type:
ACTUAL
First Submit Date:
2019-06-03
First Submit QC Date:
None
Study First Post Date:
2019-06-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-06-27
Results First Submit QC Date:
None
Results First Post Date:
2023-07-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2022-12-23
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-06-27
Last Update Post Date:
2023-07-21
Last Update Post Date Type:
ACTUAL